India Oncology-Cancer Drugs Market (2025-2031) | Size & Revenue, Industry, Share, Growth, Companies, Competitive Landscape, Value, Segmentation, Forecast, Analysis, Outlook, Trends

Market Forecast By Drug Class (Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy), By Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Other Cancers) And Competitive Landscape
Product Code: ETC7549480 Publication Date: Sep 2024 Product Type: Market Research Report
Publisher: 6Wresearch Author: Dhaval Chaurasia No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

India Oncology-Cancer Drugs Market Import Shipment Trend (2020-2024)

The India oncology-cancer drugs market import shipment demonstrated a steady growth trend with a CAGR of 3.0 from 2020 to 2024. Notably, there was a significant acceleration in growth between 2023 and 2024, with a growth rate of 26.5%, indicating a strong upward momentum in market expansion.

Graph Showing India oncology-cancer drugs market Shipment Trend & Volume from 2020-2024

Key Highlights of the Report:

  • India Oncology-Cancer Drugs Market Outlook
  • Market Size of India Oncology-Cancer Drugs Market, 2024
  • Forecast of India Oncology-Cancer Drugs Market, 2031
  • Historical Data and Forecast of India Oncology-Cancer Drugs Revenues & Volume for the Period 2021- 2031
  • India Oncology-Cancer Drugs Market Trend Evolution
  • India Oncology-Cancer Drugs Market Drivers and Challenges
  • India Oncology-Cancer Drugs Price Trends
  • India Oncology-Cancer Drugs Porter's Five Forces
  • India Oncology-Cancer Drugs Industry Life Cycle
  • Historical Data and Forecast of India Oncology-Cancer Drugs Market Revenues & Volume By Drug Class for the Period 2021- 2031
  • Historical Data and Forecast of India Oncology-Cancer Drugs Market Revenues & Volume By Chemotherapy for the Period 2021- 2031
  • Historical Data and Forecast of India Oncology-Cancer Drugs Market Revenues & Volume By Targeted Therapy for the Period 2021- 2031
  • Historical Data and Forecast of India Oncology-Cancer Drugs Market Revenues & Volume By Immunotherapy (Biologic Therapy) for the Period 2021- 2031
  • Historical Data and Forecast of India Oncology-Cancer Drugs Market Revenues & Volume By Hormonal Therapy for the Period 2021- 2031
  • Historical Data and Forecast of India Oncology-Cancer Drugs Market Revenues & Volume By Indication for the Period 2021- 2031
  • Historical Data and Forecast of India Oncology-Cancer Drugs Market Revenues & Volume By Lung Cancer for the Period 2021- 2031
  • Historical Data and Forecast of India Oncology-Cancer Drugs Market Revenues & Volume By Stomach Cancer for the Period 2021- 2031
  • Historical Data and Forecast of India Oncology-Cancer Drugs Market Revenues & Volume By Colorectal Cancer for the Period 2021- 2031
  • Historical Data and Forecast of India Oncology-Cancer Drugs Market Revenues & Volume By Breast Cancer for the Period 2021- 2031
  • Historical Data and Forecast of India Oncology-Cancer Drugs Market Revenues & Volume By Prostate Cancer for the Period 2021- 2031
  • Historical Data and Forecast of India Oncology-Cancer Drugs Market Revenues & Volume By Liver Cancer for the Period 2021- 2031
  • Historical Data and Forecast of India Oncology-Cancer Drugs Market Revenues & Volume By Esophagus Cancer for the Period 2021- 2031
  • Historical Data and Forecast of India Oncology-Cancer Drugs Market Revenues & Volume By Other Cancers for the Period 2021- 2031
  • India Oncology-Cancer Drugs Import Export Trade Statistics
  • Market Opportunity Assessment By Drug Class
  • Market Opportunity Assessment By Indication
  • India Oncology-Cancer Drugs Top Companies Market Share
  • India Oncology-Cancer Drugs Competitive Benchmarking By Technical and Operational Parameters
  • India Oncology-Cancer Drugs Company Profiles
  • India Oncology-Cancer Drugs Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the India Oncology-Cancer Drugs Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the India Oncology-Cancer Drugs Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 India Oncology-Cancer Drugs Market Overview

3.1 India Country Macro Economic Indicators

3.2 India Oncology-Cancer Drugs Market Revenues & Volume, 2021 & 2031F

3.3 India Oncology-Cancer Drugs Market - Industry Life Cycle

3.4 India Oncology-Cancer Drugs Market - Porter's Five Forces

3.5 India Oncology-Cancer Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 India Oncology-Cancer Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F

4 India Oncology-Cancer Drugs Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in India

4.2.2 Growing awareness about cancer treatment options

4.2.3 Technological advancements in oncology drugs research and development

4.3 Market Restraints

4.3.1 High cost associated with oncology-cancer drugs

4.3.2 Stringent regulatory requirements for drug approval in India

5 India Oncology-Cancer Drugs Market Trends

6 India Oncology-Cancer Drugs Market, By Types

6.1 India Oncology-Cancer Drugs Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 India Oncology-Cancer Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 India Oncology-Cancer Drugs Market Revenues & Volume, By Chemotherapy, 2021- 2031F

6.1.4 India Oncology-Cancer Drugs Market Revenues & Volume, By Targeted Therapy, 2021- 2031F

6.1.5 India Oncology-Cancer Drugs Market Revenues & Volume, By Immunotherapy (Biologic Therapy), 2021- 2031F

6.1.6 India Oncology-Cancer Drugs Market Revenues & Volume, By Hormonal Therapy, 2021- 2031F

6.2 India Oncology-Cancer Drugs Market, By Indication

6.2.1 Overview and Analysis

6.2.2 India Oncology-Cancer Drugs Market Revenues & Volume, By Lung Cancer, 2021- 2031F

6.2.3 India Oncology-Cancer Drugs Market Revenues & Volume, By Stomach Cancer, 2021- 2031F

6.2.4 India Oncology-Cancer Drugs Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F

6.2.5 India Oncology-Cancer Drugs Market Revenues & Volume, By Breast Cancer, 2021- 2031F

6.2.6 India Oncology-Cancer Drugs Market Revenues & Volume, By Prostate Cancer, 2021- 2031F

6.2.7 India Oncology-Cancer Drugs Market Revenues & Volume, By Liver Cancer, 2021- 2031F

6.2.8 India Oncology-Cancer Drugs Market Revenues & Volume, By Other Cancers, 2021- 2031F

6.2.9 India Oncology-Cancer Drugs Market Revenues & Volume, By Other Cancers, 2021- 2031F

7 India Oncology-Cancer Drugs Market Import-Export Trade Statistics

7.1 India Oncology-Cancer Drugs Market Export to Major Countries

7.2 India Oncology-Cancer Drugs Market Imports from Major Countries

8 India Oncology-Cancer Drugs Market Key Performance Indicators

8.1 Number of clinical trials conducted for oncology-cancer drugs in India

8.2 Adoption rate of innovative cancer treatment therapies in the market

8.3 Investment in research and development for oncology drugs in India

9 India Oncology-Cancer Drugs Market - Opportunity Assessment

9.1 India Oncology-Cancer Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 India Oncology-Cancer Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F

10 India Oncology-Cancer Drugs Market - Competitive Landscape

10.1 India Oncology-Cancer Drugs Market Revenue Share, By Companies, 2024

10.2 India Oncology-Cancer Drugs Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Related Reports

Industry Events and Analyst Meet

Whitepaper

Read All